There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Star Equity Holdings (STRR – Research Report), Sutro Biopharma (STRO – Research Report) and Pear Therapeutics (PEAR – Research Report) with bullish sentiments.
Star Equity Holdings (STRR)
Maxim Group analyst Tate Sullivan reiterated a Buy rating on Star Equity Holdings yesterday and set a price target of $2.25. The company’s shares closed last Monday at $0.90, close to its 52-week low of $0.72.
According to TipRanks.com, Sullivan is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Star Equity Holdings with a $2.25 average price target.
Sutro Biopharma (STRO)
Berenberg Bank analyst Zhiqiang Shu maintained a Buy rating on Sutro Biopharma today and set a price target of $26.00. The company’s shares closed last Monday at $7.64.
According to TipRanks.com, Shu has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Sutro Biopharma has an analyst consensus of Strong Buy, with a price target consensus of $20.50, a 182.0% upside from current levels. In a report issued on November 9, H.C. Wainwright also reiterated a Buy rating on the stock with a $20.00 price target.
Pear Therapeutics (PEAR)
Chardan Capital analyst Keay Nakae maintained a Buy rating on Pear Therapeutics today and set a price target of $8.00. The company’s shares closed last Monday at $2.52, close to its 52-week low of $1.34.
According to TipRanks.com, Nakae is a 3-star analyst with an average return of
Currently, the analyst consensus on Pear Therapeutics is a Strong Buy with an average price target of $6.00, implying a 101.3% upside from current levels. In a report released yesterday, BTIG also reiterated a Buy rating on the stock with a $5.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on STRR:
- Ginkgo Bioworks Holdings, Inc. Earnings Report: Is it a Beat?
- Needham Remains a Hold on AppLovin (APP)
- B.Riley Financial Keeps Their Buy Rating on Chicken Soup For The Soul Entertainment (CSSE)
- Gladstone Land (LAND) Receives a Buy from Maxim Group
- Significant Insider Trading at Lazydays Holdings (NASDAQ:LAZY)